Page last updated: 2024-08-23

simvastatin and Carcinoma, Lobular

simvastatin has been researched along with Carcinoma, Lobular in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Tena Gómez, MD; García Aroca, MÁ; López Soberón, E; Navarro Suay, R1
Chan, CW; Goh, BC; Hartman, M; Lee, SC; Loh, X; Seah, S; Wang, T1

Other Studies

2 other study(ies) available for simvastatin and Carcinoma, Lobular

ArticleYear
[Intraoperative anaphylaxis due to beta-lactams in a hypertensive patient on angiotensin ii receptor antagonists and beta-blockers].
    Revista espanola de anestesiologia y reanimacion, 2015, Volume: 62, Issue:2

    Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Anaphylaxis; Angiotensin II Type 1 Receptor Blockers; Bisoprolol; Breast Neoplasms; Carcinoma, Lobular; Drug Therapy, Combination; Female; Humans; Hypertension; Intraoperative Complications; Losartan; Mammaplasty; Mastectomy; Simvastatin

2015
Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway.
    Oncotarget, 2016, Jan-19, Volume: 7, Issue:3

    Topics: Adult; Aged; Apoptosis; Blotting, Western; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Regulation, Neoplastic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoenzyme Techniques; Mevalonic Acid; Middle Aged; Mitogen-Activated Protein Kinases; Neoplasm Grading; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Prognosis; Prospective Studies; Proto-Oncogene Proteins c-akt; Simvastatin; TOR Serine-Threonine Kinases; Tumor Cells, Cultured

2016